Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -136.49% is 124% below its 5-year average of -61.00%, around the middle of its 5-year range (-209.97%–-21.61%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.75% below its 12-month average of -127.86%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -136.49%.
RETURN ON INVESTED CAPITAL (ROIC)
-136.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-127.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-63.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-61.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-52.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.75%
CURRENT VS 3Y AVG
-114.90%
CURRENT VS 5Y AVG
-123.75%
CURRENT VS 10Y AVG
-160.02%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.45%
median of 820 covered companies
CURRENT VS SECTOR MEDIAN
-285.02%
vs the sector median at left
Larimar Therapeutics, Inc.
Market Cap
$291.45M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-127.86%
3Y Avg
-63.51%
5Y Avg
-61.00%
Market Cap
$287.37M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$285.74M
Return on Invested Capital (ROIC)
-20.40%
TTM Avg
-43.02%
3Y Avg
-57.92%
5Y Avg
-48.43%
Market Cap
$285.55M
Return on Invested Capital (ROIC)
-49.76%
TTM Avg
-54.76%
3Y Avg
-73.23%
5Y Avg
-84.98%
Market Cap
$284.80M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
Market Cap
$283.18M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$281.92M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
Market Cap
$280.91M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-4.06%
3Y Avg
-9.73%
5Y Avg
-12.88%
Market Cap
$302.90M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. (LRMR) | $291.45M | -136.49% | -127.86% | -63.51% | -61.00% |
| Standard BioTools Inc. (LAB)vs › | $287.37M | -14.06% | -26.07% | -28.37% | -26.89% |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.74M | -20.40% | -43.02% | -57.92% | -48.43% |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | -49.76% | -54.76% | -73.23% | -84.98% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $284.80M | -129.90% | -509.42% | -303.54% | -247.13% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.18M | -61.10% | -38.45% | -31.16% | -81.63% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | -27.62% | -16.38% | -32.77% | -39.71% |
| Aurora Cannabis Inc. (ACB)vs › | $280.91M | -15.69% | -4.06% | -9.73% | -12.88% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $302.90M | -122.21% | -122.21% | -122.21% | -122.21% |
| Benitec Biopharma Inc. (BNTC)vs › | $302.32M | -28.88% | -35.80% | -1011.32% | -772.02% |
ROIC
-136.5%
ROE
-135.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -136.49% |
| 2026-03-31 | -106.56% |
| 2025-12-31 | -209.97% |
| 2025-09-30 | -98.27% |
| 2025-06-30 | -88.00% |
| 2025-03-31 | -70.64% |
| 2024-12-31 | -51.68% |
| 2024-09-30 | -36.38% |
| 2024-06-30 | -30.48% |
| 2024-03-31 | -21.61% |
| 2023-12-31 | -48.31% |
| 2023-09-30 | -39.05% |
| 2023-06-30 | -34.67% |
| 2023-03-31 | -31.81% |
| 2022-12-31 | -31.57% |
| 2022-09-30 | -28.46% |
| 2022-06-30 | -78.70% |
| 2022-03-31 | -75.78% |
| 2021-12-31 | -72.28% |
| 2021-09-30 | -71.85% |
| 2021-06-30 | -67.42% |
| 2021-03-31 | -56.99% |
| 2020-12-31 | -44.73% |
| 2020-09-30 | -31.78% |
| 2020-06-30 | -27.66% |
| 2020-03-31 | -35.19% |
| 2019-09-30 | -32.09% |
| 2019-06-30 | -34.15% |
| 2019-03-31 | -43.79% |
| 2018-12-31 | -53.66% |
| 2018-09-30 | -48.06% |
| 2018-06-30 | -79.43% |
| 2018-03-31 | -65.10% |
| 2017-12-31 | -53.96% |
| 2017-09-30 | -55.38% |
| 2017-06-30 | -51.24% |
| 2017-03-31 | -47.21% |
| 2016-12-31 | -46.46% |
| 2016-09-30 | -52.79% |
| 2016-06-30 | -51.53% |
| 2016-03-31 | -48.97% |
| 2015-12-31 | -42.06% |
